OCEAN VIEW, Delaware, January 18, 2017 /PRNewswire/ -- The report "Automated Breast Ultrasound System (ABUS) Market Size By Product (Automated Breast Ultrasound System, Automated Breast Volume Scanner), By End User (Hospitals, Diagnostic Imaging Centers), Industry Analysis Report, Regional Outlook (U.S., Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Russia, China, Japan, India, Australia, Thailand, Saudi Arabia, UAE, South Africa), Application Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 - 2024", by Global Market Insights, Inc. says Automated breast ultrasound system market size is estimated to exceed USD 2 billion by 2024.

Breast cancer prevalence is increasing globally. According to ACS estimates, more than 246,600 new cases of invasive breast cancer will have been diagnosed in 2016 in the U.S. alone. Introduction of advanced technologies has made it possible to detect small cancer tumors as well as dense breast tissue scanning. This technology has gained popularity due to its non-invasive, radiation-free, and three-dimensional imaging features for breast cancer diagnosis. Rising cancer prevalence rates and emergence of better breast scanning technologies will drive automated breast ultrasound system market growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/728

Growing awareness through various programs and favorable government initiatives should fuel the automated breast ultrasound system market growth. Australian government launched breast cancer awareness campaign named "Breast Cancer won't wait, everything else can" for early diagnosis and effective treatment.

Increasing product innovation for development of more advanced breast cancer detection techniques will propel automated breast ultrasound system market growth. Automated breast volume scanner (ABVS) is a recent technological advancement that has significantly contributed to ABUS market growth.

Automated breast volume scanner (ABVS) market is slated to exceed USD 950 million by 2024, growing at more than 20% CAGR. ABVS holds benefits such as high reproducibility of images, reduced scan time, delivery of coronal view 3D images with high sensitivity. It also provides high resolution imaging with innovative applications such as fatty tissue imaging and elasticity imaging.

Strong capital investment trends along with high maintenance cost, unattractive reimbursement policies, and awareness regarding consequences of exposure to radiation could restrain automated breast ultrasound system market growth.

Ultrasound Homepage